CERE - Cerevel Therapeutics Sotuvning sof marjinal rentabelligi

cerevel.com (CERE) - korporativ logo

Cerevel Therapeutics (CERE) Parkinson kasalligi uchun inqilobiy davolash usullarini ishlab chiqish maqsadida yetakchi neyrobiologlarni birlashtiradi. Biznesning sof marja samaradorligi emitentning moliyaviy barqarorligini tasdiqlaydi, bunda 0.00 ushbu ko'rsatkichning joriy qiymatini belgilaydi. Istiqbollar shizofreniya va Altsgeymer terapiyalarining muvaffaqiyatiga bog'liq, makroiqtisodiy omillardan mustaqillik esa kompaniyani investitsiyalarning doimiy oqimiga ega bo'lgan ishonchli himoya aktiviga aylantiradi.

Cerevel Corp (CERE) Sof foyda normasi: 04.07.2022 - 10.08.2024 davri uchun

Cerevel (CERE) kompaniyasining tahliliy kesimlari

- aksiya kursi va ekspertlarning narx prognozi:
Kompaniyaning har tomonlama tahlili:cerevel.com, CERE
Cerevel Therapeutics Inc ishlab chiqargan mahsulot

Sotuv marjasi sof foydaning umumiy daromadga nisbati sifatida belgilanadi. Ushbu ko'rsatkich barcha operatsion va moliyaviy xarajatlar qoplanganidan keyin Cerevel Therapeutics (CERE) tasarrufida qolgan mablag'lar qismini aks ettiradi. Laboratoriya tadqiqotlarining robotlashtirilishi xodimlar xarajatlarini minimallashtirib, yakuniy daromadlilikka bevosita ta'sir ko'rsatadi. Joriy sof sotuvlar daromadliligining tahlili ushbu texnologik modelning samaradorligini baholash imkonini beradi, holbuki past qiymatlar "qiymat tuzog'i" xavfi haqida signal berishi mumkin.

Raqobatchilar tahlili

BIIB: Sotuvning sof marjinal rentabelligi|Sof marja Neurocrine Biosciences Inc (NBIX)|RGC (Regencell Corp) - Sotuvning sof marjinal rentabelligi|AXSM: Sof foyda normasi|Sof marja acadia-pharm.com (ACAD)|Sotuvning sof marjinal rentabelligi Xenon Pharmaceuticals (XENE)|Sof marja Viking Therapeutics VKTX|Sof foyda normasi SUPN|CPRX - Sof marja|Sof marja Denali Therapeutics|HRMY: Sotuvning sof marjinal rentabelligi|Biohaven - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi AMLX|Trevi Therapeutics, Inc. (TRVI) - Kompaniya sotuv marjasi|Sof foyda bo'yicha sotuv rentabelligi PRAX (Praxis Medicines)|Anavex Corp - Sotuvning sof rentabelligi|Sof marja CeriBell CBLL|Kompaniya sotuv marjasi Prothena Biosciences (PRTA)|ALEC: Sof foyda bo'yicha sotuv rentabelligi|ANNX - Sotuvning sof marjinal rentabelligi|Omeros Corp. (OMER) - Sof marja|Sof marja Neurogene Inc. (NGNE)|Sof foyda bo'yicha sotuv rentabelligi ACIU|Sof marja VYGR|Sof marja Neumora (NMRA)|SCLX - Sof marja|Sotuvning sof marjinal rentabelligi TVGN (Tevogen Bio Holdings Inc.)|Sof foyda normasi ACOG|Cognition Therapeutics Inc. - Sotuvning sof marjinal rentabelligi|IKT - Sotuvning sof marjinal rentabelligi|SAVA: Sotuvning sof marjinal rentabelligi|Assertio Holdings, Inc. - Sof foyda normasi|COYA (Coya) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi VTGN (Vistagen Therapeutics)|Sof marja Ovid Rx (OVID)|Acumen Pharmaceuticals - Sotuvning sof rentabelligi|Sof marja CervoMed, Inc. CRVO|Sotuvning sof marjinal rentabelligi Alterity Therapeutics ATHE|CLNN: Sof foyda bo'yicha sotuv rentabelligi|PEPG (pepgen.com) - Sotuvning sof rentabelligi|Jupiter Neurosciences Inc (JUNS) - Sof marja|Relmada Therapeutics - Sof foyda normasi|ANVS (Annovis Bio Inc) - Sotuvning sof marjinal rentabelligi|GRCE: Sof foyda normasi|Sof marja Firefly Neuroscience Inc (AIFF)|KLTO (ANEW Medical) - Sof foyda normasi|Sof marja neurosense-tx.com NRSN|Reviva Pharmaceuticals Holdings, Inc. (RVPH) - Sof marja|MTVA: Sof foyda bo'yicha sotuv rentabelligi|NeurAxis, Inc (NRXS) - Sof foyda bo'yicha sotuv rentabelligi|HSDT: Sotuvning sof marjinal rentabelligi|PASG - Kompaniya sotuv marjasi|Sof marja Neuphoria Therapeutics, Inc.|Sof marja NERV|Sotuvning sof marjinal rentabelligi ATHA|ADXN (Addex Therapeutics Ltd) - Sof foyda normasi|Sof marja alzamend.com ALZN|Kompaniya sotuv marjasi Cyclerion Therapeutics (CYCN)|Protagenic - Sotuvning sof marjinal rentabelligi|Sof foyda normasi KTTA (Pasithea Therapeutics Corp)|CRGT: Sotuvning sof marjinal rentabelligi|Avenue Therapeutics Inc. (ATXI) - Sotuvning sof marjinal rentabelligi|BCLI (BrainStorm Cell Therapeutics Inc.) - Sotuvning sof marjinal rentabelligi|Sotuvning sof marjinal rentabelligi Cara Therapeutics Inc|Sof marja Chromocell Therapeutics (CHRO)|Kompaniyaning sof rentabelligi ELYM|Sof marja Intra-Cellular ITCI|LBPH: Sotuvning sof rentabelligi|MRNS - Sof marja|NKGen Biotech, Inc. (NKGN) - Sof foyda bo'yicha sotuv rentabelligi|neurobopharma.com (NRBO) - Sof marja|SAGE: Kompaniyaning sof rentabelligi|Sof marja Synaptogenix, Inc.|Sof marja TRVN|Sotuvning sof marjinal rentabelligi VIGL|Sotuvning sof marjinal rentabelligi anewmeds.com (WENA)